Academic Year: | 2018/9 |
Owning Department/School: | Department of Pharmacy & Pharmacology |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
- Modular (no specific semester)
|
Assessment Summary: | CW 100% |
Assessment Detail: |
- Assessment Group A: Medicines Optimisation Tool (ass't grp A) (CW 40%)
- Assessment Group A: Case Based Discussion (ass't grp A) (CW 20%)
- Assessment Group A: CARE Tool (ass't grp A) (CW 10%)
- Assessment Group A: Teaching Session (ass't grp A) (CW 30%)
- Assessment Group B: Medicines Optimisation Tool (ass't grp B) (CW 40%)
- Assessment Group B: Case Based Discussion (ass't grp B) (CW 20%)
- Assessment Group B: CARE Tool (ass't grp B) (CW 10%)
- Assessment Group B: NICE Review (ass't grp B) (CW 30%)
- Assessment Group C: Medicines Optimisation Tool (ass't grp C) (CW 40%)
- Assessment Group C: Case Based Discussion (ass't grp C) (CW 20%)
- Assessment Group C: CARE Tool (ass't grp C) (CW 10%)
- Assessment Group C: Formulary Application / TCR (ass't grp C) (CW 30%)
- Assessment Group D: Medicines Optimisation Tool (ass't grp D) (CW 40%)
- Assessment Group D: Case Based Discussion (ass't grp D) (CW 20%)
- Assessment Group D: CARE Tool (ass't grp D) (CW 10%)
- Assessment Group D: Designated Alternative ASP (ass't grp D) (CW 30%)
|
Supplementary Assessment: |
- Like-for-like reassessment (where allowed by programme regulations)
|
Requisites: |
|
Description:
| Aims: This clinical module aims to update pharmacists on malignant diseases and patient monitoring factors that should be considered when providing pharmaceutical care for these patients.
Learning Outcomes: On successful completion of this unit the student will be able to:-
1. Describe and analyse the role of the pharmacist in prescribing, administration and monitoring of medication for patients with malignant diseases (knowledge and understanding)
2. Explain the disease and patient monitoring factors in malignant diseases (knowledge and understanding, professional practical skill)
3. Critically evaluate the evidence base for the management of common malignancies and the complications of management (intellectual skill)
4. Reflect on their own practice in supporting patients with malignant diseases and identify areas for continuous improvement (personal transferable skill)
5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding)
Skills:
* Planning & organisation (Taught/Facilitated)
* Handling information (Taught/Facilitated/Assessed)
* Written communication (Taught/Facilitated/Assessed)
* Working with others (Taught/Facilitated)
* Scientific & practical skills (Taught/Facilitated/Assessed)
* Improving learning & performance (Taught/Facilitated/Assessed)
* Problem solving (Taught/Facilitated)
Content:
* Introduction to Cancer
* Basics of Cancer Chemotherapy
* Complications with Chemotherapy
* Management of Patients with Solid Tumours
* Leukaemia and Lymphoma
* Drug Administration and Drug Delivery Systems in Oncology.
|
Programme availability: |
PA50188 is Optional on the following programmes:
Department of Pharmacy & Pharmacology
- TSPA-ADT16 : Modular Programme in Advanced and Specialist Practice
- TSPA-ADM16 : MSc Advanced and Specialist Healthcare Practice
- TSPA-ADM07 : MSc Clinical Pharmacy Practice (Secondary Care)
- TSPA-ADM18 : MSc Clinical Pharmacy Practice (Secondary Care)
- TSPA-ADM12 : MSc Prescribing & Therapeutics
- TSPA-ADM19 : MSc Prescribing & Therapeutics
- TSPA-ADC16 : PG Cert Advanced and Specialist Healthcare Practice
- TSPA-ADC09 : PG Cert Clinical Pharmacy Practice (Secondary Care)
- TSPA-ADC18 : PG Cert Clinical Pharmacy Practice (Secondary Care)
- TSPA-ADC15 : PG Cert Prescribing & Therapeutics
- TSPA-ADC19 : PG Cert Prescribing & Therapeutics
- TSPA-ADL16 : PG Dip Advanced and Specialist Healthcare Practice
- TSPA-ADL08 : PG Dip Clinical Pharmacy Practice (Secondary Care)
- TSPA-ADL18 : PG Dip Clinical Pharmacy Practice (Secondary Care)
- TSPA-ADL12 : PG Dip Prescribing & Therapeutics
- TSPA-ADL19 : PG Dip Prescribing & Therapeutics
|